The expression of both the H2AX gene and miR-24-2 in individual patients with tumors at different stages was again observed to have an inverse relation (Figure 3c), confirming miR-24-2 as a strong regulator of H2AX in in vivo sporadic breast tumors. The gene discussed is H2AX; the disease is breast neoplasm.